✦ LIBER ✦

Methotrexate, Cisplatin and Carboplatin as Single Agents and in Combination for Metastatic Bladder Cancer

✍ Scribed by R.T.D. OLIVER; H.K. KWOK; W.J. HIGHMAN; J. WAXMAN

Book ID: 115193616
Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 455 KB
Volume: 58
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.1986.tb05423.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin, Ifosfamide, Methotrexate and

Cisplatin, Ifosfamide, Methotrexate and Vinblastine Combination Chemotherapy for Metastatic Urothelial Cancer

✍ Kyriakakis, Zacharias; Dimopoulos, Meletios A.; Kostakopoulos, Athanassios; Kara 📂 Article 📅 1997 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 439 KB

Comparison of single agent cisplatin and

Comparison of single agent cisplatin and cisplatin containing combinations in treatment of murine bladder cancer

✍ David P. Hickey; Maurizio Brausi; Anthony F. Blatnik; Mark S. Soloway 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 453 KB

Carboplatin, methotrexate, and vinblasti

Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapy

✍ J. Bellmunt; J. Albanell; O. S. Gallego; A. Ribas; P. Vicente; J. Carulla; J. De 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

Background. A Phase I1 trial with a new regimen of methotrexate, carboplatin, and vinblastine (M-CAVI) was conducted for patients with bladder cancer who could not receive cisplatin-based chemotherapy. Methods. Treatment consisted of methotrexate (30 mg/m2) on days 1,15, and 22; carboplatin (300 mg

Use of methotrexate, vinblastine, adriam

Use of methotrexate, vinblastine, adriamycin, and cisplatin in combination with radiation and hyperthermia as neo-adjuvant therapy for bladder cancer

✍ Sumio Noguchi; Yoshinobu Kubota; Takeshi Miura; Taro Shuin; Masahiko Hosaka 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 313 KB

Intra-arterial administration of methotr

Intra-arterial administration of methotrexate, Adriamycin, and cisplatin as neoadjuvant chemotherapy for bladder cancer

✍ Manabu Kuriyama; Yoshito Takahashi; Yukihiro Nagatani; Ikuo Shinoda; Naoki Yamam 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 343 KB

Gemcitabine with cisplatin has a better

Gemcitabine with cisplatin has a better safety profile and similar survival rates as methotrexate, vinblastine, doxorubicin and cisplatin for those with advanced or metastatic bladder cancer

✍ Malcolm J. Moore 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 187 KB